-
Pulmonx Pursues $100 Million U.S. IPO
24 Sep 2020 23:54 GMT
… (OTC:OCPNF) Broncus Medical Circassia Pharma AstraZeneca (AZN) GlaxoSmithKline … Listed underwriters of the IPO are BofA Securities, Morgan … that growth. Additionally, the IPO appears pricey given that … .S. IPOs with IPO Edge research.
Members of IPO Edge get …
-
Pulmonx Files Initial U.S. IPO Registration Statement
07 Mar 2020 07:43 GMT
… opinion when we learn more IPO details. Company & … System (OTC:OCPNF) Broncus Medical Circassia Pharma AstraZeneca (AZN) GlaxoSmithKline … . Listed bookrunners of the IPO are BofA Securities, Morgan … U.S. IPOs with IPO Edge research.
Members of IPO Edge get …
-
Circassia, which has US headquarters in Morrisville, receives 2 boosts for lung products
12 Jul 2019 13:13 GMT
… for its asthma products.
Circassia, a specialty pharmaceutical company … .
Purchasing Agreement Signed
Circassia was awarded a group … important Premier contract brings Circassia one step closer to … 2014 it completed an initial public offering of stock on the …
-
FDA approves lung disease treatment from Circassia, which has HQ in Morrisville
18 Apr 2019 18:02 GMT
… and regulatory submission. Circassia also has the commercial … ,” said David Acheson, Circassia’s senior vice president … knowing it.
Circassia focused on respiratory disease
Circassia is a … 2014 it completed an initial public offering of stock on the …
-
Circassia, with US HQ in Morrisville, to acquire rights to newborn respiratory device
25 Jan 2019 14:35 GMT
… pharmaceutical business,” said Steve Harris, Circassia’s chief executive officer. “With … administration of inhaled nitric oxide.
Circassia growing in respiratory disease market … . In 2014 it completed an initial public offering on the London Stock Exchange …
-
Circassia acquires rights to COPD drug, expanding staff
28 Dec 2018 20:35 GMT
… million.
Tudoza delivery system. Circassia photo.
Circassia said it would satisfy the … .
Recruited to Morrisville in 2012
Circassia, headquartered in Oxford, England, was … March 2014 it completed an initial public offering on the London Stock Exchange …
-
Circassia seeks shift to AIM after failing LSE criteria
12 Dec 2018 13:23 GMT
… will be de-listed.
Circassia’s £200m IPO on the LSE four … a time when US biotech IPOs are running at their highest … for many years.
Since its IPO, Circassia has suffered a string of … said the takeover will give Circassia “significantly more control of the …
-
GEMS picks JP Morgan, Credit Suisse and Bank of America for $5 bln IPO -sources
04 Dec 2017 10:51 GMT
::
Reuters News
By Dasha AfanasievaLONDON, Dec 4 (Reuters) - GEMS Education's owners have
[4 Dec '17 10:45]
LONDON, Dec 4 (Reuters) - Toys R Us UK is to seek creditor
[4 Dec '17 10:09]
Dec 4 (Reuters) - British wholesaler and convenience
[4 Dec …
-
Circassia gives up on allergy R&D as placebo effect scuppers another trial
18 Apr 2017 23:22 GMT
… to be speculative, and Circassia had to cut costs by … in early clinical testing.
Circassia also recently formed a partnership … up to $230m, with Circassia giving AZ $50m in shares … raised £200m through an initial public offering (IPO) on the stock exchange in …
-
‘Biotech is the ultimate impact investment’ — family offices can’t get enough of it
15 May 2023 04:32 GMT
… , Oxford-based Circassia Pharmaceuticals, an allergy specialist, launched a £581mn initial public offering, a …